About Biomérieux/NephroCheck
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics for more than 50 years, bioMérieux is present in more than 150 countries through a large network of distributors. bioMérieux owns and licenses the NEPHROCHECK® test. NEPHROCHECK® received 510(k)-clearance through the FDA’s de novo classification and is CE-marked and available in Europe. For more information on the NEPHROCHECK® test visit www.nephrocheck.com